Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a "real-world" setting.

Smith SE, McCoy-Gross K, Malcolm A, Oranski J, Markway JW, Miller TM, Bucelli RC

Open source

DOI
10.1002/acn3.52264
Published
2025 Feb
Container
Annals of clinical and translational neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.52264,
  title = {Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a "real-world" setting.},
  author = {Smith SE and McCoy-Gross K and Malcolm A and Oranski J and Markway JW and Miller TM and Bucelli RC},
  year = {2025},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.52264},
  url = {https://doi.org/10.1002/acn3.52264}
}

RIS

TY  - JOUR
TI  - Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a "real-world" setting.
AU  - Smith SE
AU  - McCoy-Gross K
AU  - Malcolm A
AU  - Oranski J
AU  - Markway JW
AU  - Miller TM
AU  - Bucelli RC
PY  - 2025
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.52264
UR  - https://doi.org/10.1002/acn3.52264
ER  - 

APA

SE, S., K, M., A, M., J, O., JW, M., TM, M., & RC, B. (2025). Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a "real-world" setting.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.52264

Source records